Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Erbitux and platinum-based chemotherapy increases survival in SCCHN

April 11, 2007

Amgen updates Vectibix progress

April 11, 2007

Survival benefit for lenalidomide plus low-dose dexamethasone in multiple myeloma

April 11, 2007

Genta files appeal against FDA decision on Genasense for CLL

April 11, 2007

Novel series of anticancer compounds disclosed in recent patents

April 11, 2007

Ceflatonin studied in new phase II/III study in CML

April 10, 2007

SuperGen completes sale of remaining Nipent rights

April 10, 2007

Tasquinimod enhances response to androgen ablation in prostate cancer models

April 10, 2007

Novel anticancer compounds reported in recent patent literature

April 10, 2007

Pharmacyclics' NDA for Xcytrin to be filed over protest

April 5, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...